Thirty-three core targets of SGLT2 inhibitors in the treatment of DM with HF were screened (Fig. 5), among which red, orange, yellow and purple nodes represent a gradual decrease in the degree value from large to small. The gene discussed is SLC5A2; the disease is hydrops fetalis.